A review from five studies has found no added benefit of using Daiichi Sankyo’s Radicava (edaravone) and Sanofi’s Rilutek ...

Background Double sequential defibrillation (DSD) is a promising treatment for patients with out-of-hospital cardiac arrest ...

Uranium levels exceeding EPA limits were detected in wells to the Southwest Idaho Treatment Center in Nampa. Water testing is ...

Dr. Dr. Ahmad Aziz, a scientist at DZNE's Bonn site, has been awarded a „Proof of Concept Grant“ from the European Research Council (ERC). He aims to further develop innovative software for analyzing ...

The plan's most telling feature is what it left out. Two months before the announcement, Pfizer and Valneva reported that their Lyme vaccine had passed its final major trial, cutting confirmed cases ...

Researchers from University of Arizona present a new therapeutic target to shield nerve cells from the damage of ALS.

Oral PrimeC for ALS significantly reduced toxic TDP-43 protein levels in a Phase 2b trial. PrimeC also slowed functional decline and extended survival by about 15 months. The treatment was well ...

A new study reveals experimental drug XL20 crosses the blood-brain barrier to stop toxic TDP-43 clumping in ALS.

Amyotrophic lateral sclerosis (ALS) received widespread attention in the summer of 2014 thanks to the Ice Bucket Challenge. Millions of people participated, drenching themselves in ice-cold water to ...

A newly identified experimental compound, XL20, has demonstrated neuroprotective effects in mouse models and human motor ...

Whole-body MRI (WB-MRI) may improve ALS diagnostic certainty. WB-MRI assesses muscle swelling (edema) as a marker for lower ...

Two innovative, forward-thinking organizations show how rebuilding patient trust is becoming the real breakthrough driving ...